Norma Sebestyen

At Ayogo, we activate, engage and empower patients faced with challenging healthcare transitions. Ayogo's highly-scalable behavioral support platform creates value for innovative life sciences companies by helping their patients successfully transition on to therapy. Our "dynamic tailoring" technology allows us to ensure the support we provide is personal, relevant, and timely, and based on each patient's unique psychosocial context. Our growing team cares deeply about doing meaningful, innovative work: we've developed an incredible product, empowering patients and providers around the globe, while creating a culture that nourishes this spirit. Ayogo has twice been recognized as one of the top 100 most innovative digital health companies, and is broadly recognized for its progressive corporate culture. Join our team: ayogo.com/careers/

Inflammatory bowel disease (IBD) is an unpreventable, complex, chronic, relapsing and often debilitating lifelong disease that does not yet have a cure. The two main types of IBD are Crohn’s disease and ulcerative colitis. Both are caused when the intestine’s immune system responds aggressively or inappropriately to intestinal matter and attacks healthy tissue inside the digestive system. Patients experience disrupting and embarrassing bowel issues and crippling pain. Other symptoms include cramping, nausea, vomiting, fatigue, reduced appetite and weight loss. IBD can lead to life-threatening complications. In addition to physical ailments, IBD can lead to mental-health concerns, repeated and costly hospital admissions, long-term and high-priced drug reliance, and significant lost school time, work time and economic opportunity. Early, accurate diagnosis and modern treatment have the power to significantly decrease the physical and social burdens of the disease. Seeing the necessity and urgency for improved delivery and management of care, a group of IBD specialists has formed a non-profit society and reached out to other stakeholders to help to improve the lives of the 25,000 British Columbian adults, youth and children struggling with IBD, by delivering province-wide efficient and effective modern care through the proposed IBD Centre of BC. As a multidisciplinary full-time clinic, education and research centre serving IBD patients and specialists throughout the province, The IBD Centre of BC will address the challenges facing IBD patients, their families and the health-care system in BC. The IBD Centre of BC will operate on a sustainable model that combines MSP-covered practitioners with fee-based practitioners. Our goal is to secure funding for non-MSP services from both the province and donors so that all IBD-related services will be provided at no charge to patients after receipt of a physician’s referral.

The UBC Sauder School of Business is Canadas leading academic business school, maintaining an international reputation for excellence in research and learning, and unmatched global partnerships. The faculty has more than 2,700 students in Bachelors, Masters and PhD programs, and boasts over 40,000 alumni in 80 countries. Located in Vancouver at the University of British Columbia, rated by the Economist Intelligent Unit as the worlds top city in its global liveability rankings, the school draws from the internationalism of the city and its Pacific Rim setting to provide an unrivalled global business perspective. The school is situated in the heart of the spectacular UBC campus, home to forest, ocean and mountain vistas. A second campus, Robson Square, is located in the heart of Vancouvers bustling downtown peninsula. The business school was renamed the Sauder School of Business in 2003 in recognition of the support and generosity of William Sauder, BCom 1948, Chancellor Emeritus of UBC and former Chairman of Interfor.

We are using telehealth to change people's lives.

At Ayogo, we activate, engage and empower patients faced with challenging healthcare transitions. Ayogo's highly-scalable behavioral support platform creates value for innovative life sciences companies by helping their patients successfully transition on to therapy. Our "dynamic tailoring" technology allows us to ensure the support we provide is personal, relevant, and timely, and based on each patient's unique psychosocial context. Our growing team cares deeply about doing meaningful, innovative work: we've developed an incredible product, empowering patients and providers around the globe, while creating a culture that nourishes this spirit. Ayogo has twice been recognized as one of the top 100 most innovative digital health companies, and is broadly recognized for its progressive corporate culture. Join our team: ayogo.com/careers/

Inflammatory bowel disease (IBD) is an unpreventable, complex, chronic, relapsing and often debilitating lifelong disease that does not yet have a cure. The two main types of IBD are Crohn’s disease and ulcerative colitis. Both are caused when the intestine’s immune system responds aggressively or inappropriately to intestinal matter and attacks healthy tissue inside the digestive system. Patients experience disrupting and embarrassing bowel issues and crippling pain. Other symptoms include cramping, nausea, vomiting, fatigue, reduced appetite and weight loss. IBD can lead to life-threatening complications. In addition to physical ailments, IBD can lead to mental-health concerns, repeated and costly hospital admissions, long-term and high-priced drug reliance, and significant lost school time, work time and economic opportunity. Early, accurate diagnosis and modern treatment have the power to significantly decrease the physical and social burdens of the disease. Seeing the necessity and urgency for improved delivery and management of care, a group of IBD specialists has formed a non-profit society and reached out to other stakeholders to help to improve the lives of the 25,000 British Columbian adults, youth and children struggling with IBD, by delivering province-wide efficient and effective modern care through the proposed IBD Centre of BC. As a multidisciplinary full-time clinic, education and research centre serving IBD patients and specialists throughout the province, The IBD Centre of BC will address the challenges facing IBD patients, their families and the health-care system in BC. The IBD Centre of BC will operate on a sustainable model that combines MSP-covered practitioners with fee-based practitioners. Our goal is to secure funding for non-MSP services from both the province and donors so that all IBD-related services will be provided at no charge to patients after receipt of a physician’s referral.

The UBC Sauder School of Business is Canadas leading academic business school, maintaining an international reputation for excellence in research and learning, and unmatched global partnerships. The faculty has more than 2,700 students in Bachelors, Masters and PhD programs, and boasts over 40,000 alumni in 80 countries. Located in Vancouver at the University of British Columbia, rated by the Economist Intelligent Unit as the worlds top city in its global liveability rankings, the school draws from the internationalism of the city and its Pacific Rim setting to provide an unrivalled global business perspective. The school is situated in the heart of the spectacular UBC campus, home to forest, ocean and mountain vistas. A second campus, Robson Square, is located in the heart of Vancouvers bustling downtown peninsula. The business school was renamed the Sauder School of Business in 2003 in recognition of the support and generosity of William Sauder, BCom 1948, Chancellor Emeritus of UBC and former Chairman of Interfor.